# Ingredion Incorporated account plan

> Ingredion turns corn, tapioca and other plants into starches, sweeteners and texturizers: $7,219 million 2025 net sales, about 11,200 employees.

## At a glance

Ingredion Incorporated, headquartered in Bridgewater, New Jersey, makes starches, sweeteners, texturizers, sugar reduction ingredients and pea protein from corn, tapioca, potato and other plant materials for customers in over 60 industries, mainly food, beverage, brewing, animal nutrition and industrial markets. It runs 41 active manufacturing facilities and joint venture partnerships and 30 Ingredion Idea Labs. In 2025 net sales were $7,219 million (down 3 percent), operating income $1,016 million and net income attributable to Ingredion $729 million. It had approximately 11,200 employees, files with the SEC, and agreed in June 2026 to acquire Tate & Lyle PLC.

## Business units

- **Texture & Healthful Solutions (T&HS)** (about 33% of 2025 net sales ($2,397 million)): A global segment selling modified and native starches, clean-label texturizers, hydrocolloids and customised formulations at higher prices, from 20 manufacturing facilities in the U.S., Canada, Asia-Pacific and Europe. Volume grew for the tenth consecutive quarter in Q3 2026, with Clean Label Solutions sales up 8% year-to-date. Led by Patrick I. Kalotis, Executive Vice President, Global Texture & Healthful Solutions.
- **Food & Industrial Ingredients–LATAM** (about 32% of 2025 net sales ($2,341 million)): Nine plants in Mexico, Brazil, Colombia and Peru making starches, sweeteners and co-products for local food, beverage and brewing customers; brewing is 17 percent of segment sales. Q3 2026 net sales rose 7 percent to $624 million, while operating income fell on Mexican currency effects and the Colombia earthquake. Led by Rob Ritchie, SVP Food & Industrial Ingredients.
- **Food & Industrial Ingredients–U.S./Canada** (about 28% of 2025 net sales ($2,013 million)): Six corn wet-milling plants in Ontario, Illinois, Iowa and North Carolina supplying food, beverage and industrial uses such as paper, packaging and pharmaceuticals. The April 2026 thermal event at the Argo (Bedford Park) plant cut year-to-date operating income 44 percent to $144 million.
- **All Other** (about 6% of 2025 net sales ($468 million)): Sugar reduction ingredients, mainly PureCircle stevia, and pea protein from Protein Fortification; the Pakistan business was sold at the end of Q2 2026. Michael J. Leonard is SVP, Chief Innovation Officer and Head of Protein Fortification.

## Strategic priorities

- **Close and integrate Tate & Lyle**: The all-cash acquisition, at an enterprise value of approximately £3.7B ($5.0B), is expected to complete in the second half of 2027, with run-rate net cost synergies of approximately $130 million by the end of 2030.
- **Grow specialty ingredients**: Clean label, texture, sugar reduction and protein fortification drive T&HS, and after the deal more than half of revenue is expected to come from Texture and Healthful Solutions.
- **Restore Argo and F&II U.S./Canada**: Lower Argo costs and rebuild volumes, with F&II U.S./Canada operating income guided down 35-40% for 2026.
- **Productivity and footprint**: Closures of Vanscoy, Goole, Alcantara and Cabo, the Pakistan sale, and pricing and enterprise productivity to offset inflation; more consolidation sites await the Tate & Lyle network review.
- **Higher-margin adjacencies**: Personal care, beauty care and pharma, including the Sanstar partnership in India for pharmaceutical excipients, and industrial products such as PFAS alternatives and bio-based corrugating adhesives.
- **Return on capital**: The long-term objective is Adjusted ROIC above 10.0 percent; 2025 Adjusted ROIC was 15.5 percent.

## Latest results

In Q3 2026 net sales were $1,792 million against $1,816 million, down 1 percent; excluding the Pakistan business sold at the end of Q2 they rose 2 percent. Reported operating income fell 19 percent to $201 million and adjusted EPS was $2.28 against $2.75, as Argo's slower financial recovery, higher tapioca and input costs and consumer softness weighed. Year-to-date operating income was $592 million against $796 million. Full-year 2026 guidance calls for flat net sales, adjusted operating income down mid-teens and adjusted diluted EPS of $9.25 to $9.70.

## Investments and deals

- **Acquisition of Tate & Lyle**: An offer of 595 pence per share announced on June 8, 2026, valuing the equity at approximately £2.7 billion; shareholders approved it and regulatory reviews are under way.
- **Capital expenditure**: Capex guided at $450 million to $490 million for 2026, including redundancy investments at Argo, after $433 million in 2025.
- **Global Innovation headquarters**: A new headquarters in Bridgewater, expected ready in the first half of 2028, based on an estimated construction cost of about $145 million.
- **Innovation and digital tools**: Launch of Ask Ingredion, an AI-powered formulation platform, the acquisition of the prebiotic Benicaros, and expanded Cedar Rapids capacity for industrial products.
- **Divestment of Pakistan**: The majority stake in the Pakistan business was sold in Q2 2026, with a net gain of $44 million.

## Challenges and risks

- **Argo plant recovery**: An April 2026 thermal event hit the Argo plant; production is stable but corn extraction yields remain below historical rates and maintenance spend is ahead of budget.
- **Input and energy costs**: Tapioca costs were up about 65% versus last year after a Thai root shortage, and record diesel raised utilities, freight and logistics costs.
- **Consumer softness**: Middle- and lower-income households are buying fewer units or trading down, weakening soft drinks, confectionery and packaged foods in the U.S. and Canada.
- **Integration and leverage**: Pro forma net leverage at completion of approximately 3.0x, plus integration risk and diversion of management attention.
- **Reformulation and trade policy**: Health concerns may lead customers to reformulate away from sweeteners, starches or texturizers, and tariffs and U.S. trade policy affect raw materials, energy, freight and demand.

## What leadership says

> "Combining Ingredion and Tate & Lyle's complementary portfolios establishes a global leader in ingredient solutions with the innovation expertise and geographic reach that will help create the future of food" — Jim Zallie, Chairman, President and CEO, Tate & Lyle acquisition announcement, 2026-06-08

> "Our third quarter results fell short of our expectations, largely due to Argo's slower than anticipated financial recovery, with incremental pressure from higher input costs and consumer softness" — Jim Zallie, Chairman, President and CEO, Third Quarter 2026 results press release, 2026-11-05

> "production recovery and financial recovery are at different stages." — Jim Zallie, Chairman, President and CEO, On the Argo plant, Q3 2026 earnings call, 2026-11-05

> "a lot more cautious, especially towards the volumes in the current market conditions" — Diego Reynoso, EVP and CFO, On the 2026 guidance range, Q3 2026 earnings call, 2026-11-05


## Where a supplier can help

- **Integration support**: The Tate & Lyle integration, with 'day 1 readiness' planning and $130 million of targeted synergies, opens room for integration, systems consolidation and supply network advisers.
- **Plant reliability and maintenance**: Argo's below-par yields, high maintenance spend and redundancy capex point to reliability engineering, maintenance and process optimisation suppliers.
- **Energy, freight and logistics**: Record diesel and freight costs and the cost of supplying customers across the U.S. network make logistics and energy cost tools relevant to the cost challenge.
- **Formulation and customer insight**: Clean label growth, Ask Ingredion and investment in consumer insights for reformulation briefs fit data, AI and consumer research suppliers.
- **Sales coverage of new segments**: The revamped solution selling model targets private label co-manufacturers, insurgent brands through inside sales and food service, which calls for sales enablement and prospecting tools.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Form 10-K for the fiscal year ended December 31, 2025](https://www.sec.gov/Archives/edgar/data/1046257/000162828026008603/ingr-20251231.htm)

Annual report · 2026-02-17

- Ingredion is a global ingredient solutions provider turning corn, tapioca, potato, peas, rice, stevia and other plant materials into starches, sweeteners and specialty ingredients for food, beverage, brewing, animal nutrition and industrial customers in over 60 industries; starches were 50 percent and sweeteners 34 percent of 2025 net sales.
- FY2025: net sales down 3 percent to $7.2 billion (lower corn pass-through and lower volumes), operating income up 15 percent to $1,016 million, net income attributable to Ingredion $729 million, diluted EPS $11.18, gross margin 25 percent.
- Three reportable segments: Texture & Healthful Solutions ($2,397 million net sales, operating income up 16 percent to $405 million), F&II–LATAM ($2,341 million, $493 million) and F&II–U.S./Canada ($2,013 million, operating income down 16 percent to $315 million on lower volumes and production challenges at a large plant); All Other (stevia/PureCircle, sugar reduction, pea protein, Pakistan) $468 million.
- Food is 58 percent of net sales, beverage 9 percent, brewing 7 percent, animal nutrition 7 percent; no customer above 10 percent. U.S. sales $2,815 million, Mexico $1,392 million, Brazil $572 million.
- About 11,200 employees, 41 active manufacturing facilities, over 500 scientists and engineers across 30 Ingredion Idea Labs, more than 1,800 patents and patents pending.
- Capital allocation: $433 million capex and mechanical stores in 2025, $400-440 million committed for 2026; $224 million of buybacks (1.8 million shares) and $211 million of dividends; net debt to Adjusted EBITDA 0.6; Adjusted ROIC 15.5 percent against a long-term objective above 10.0 percent.
- Portfolio moves: agreement (September 2025) to sell 51 percent of the Pakistan business to Nishat Group; plants at Vanscoy, Goole and Alcantara closed after 2024 impairments; new Global Innovation headquarters in Bridgewater, New Jersey (about $145 million construction, ready in the first half of 2028).
- Main risks: consumer and health-driven reformulation away from sweeteners, corn and raw material volatility (40-60 percent of finished product cost), energy (about 9 percent of product cost), tariffs and trade policy, plant operating difficulties, FX in Mexico and Latin America, cyber and AI risks.

### [Form 10-Q for the quarter ended September 30, 2026](https://www.sec.gov/Archives/edgar/data/1046257/000162828026071518/ingr-20260930.htm)

Interim report · 2026-11-06

- Pending acquisition of Tate & Lyle PLC agreed on June 8, 2026: all-cash recommended offer valuing Tate & Lyle's equity at about £2.7 billion (about $3.5 billion), via a UK scheme of arrangement, expected to complete in the second half of 2027.
- Q3 2026 net sales $1,792 million (down 1 percent; up 2 percent excluding the Pakistan business sold at the end of Q2); gross margin 22 percent vs 25 percent; net income attributable to Ingredion $142 million vs $171 million.
- Year-to-date net sales $5,434 million vs $5,462 million; operating income down 26 percent to $592 million, hit by a second-quarter thermal event at the Bedford Park (Argo) plant and higher manufacturing and raw material costs.
- T&HS Q3 net sales $610 million, operating income down 10 percent to $95 million (tapioca and manufacturing costs); F&II–LATAM net sales up 7 percent to $624 million, operating income down 6 percent to $109 million (Mexico currency, Colombia earthquake).
- F&II–U.S./Canada Q3 operating income down 36 percent to $52 million on Argo manufacturing costs; year-to-date down 44 percent to $144 million.
- Financing for the deal: $2,750 million bridge facility and $1,475 million delayed draw term loan, £2.8 billion of FX hedges; $59 million of acquisition-related costs year-to-date, including $42 million of FX losses.
- Year-to-date: $44 million gain on the Pakistan majority sale, $48 million of costs for closing the Cabo, Brazil plant, $26 million gain on land sold in Australia; capex $313 million, full-year commitment $450-490 million.

### [Ingredion Incorporated Reports Third Quarter 2026 Results (press release, Exhibit 99)](https://www.sec.gov/Archives/edgar/data/1046257/000162828026070486/ingr-20260930xexx99.htm)

Interim report · 2026-11-05

- Q3 2026 reported and adjusted operating income both down 19 percent ($201 million reported, $206 million adjusted); reported diluted EPS $2.23 and adjusted $2.28, vs $2.61 and $2.75.
- Net sales $1,792 million, down 1 percent; excluding Pakistan up 2 percent on FX and higher F&II–LATAM and T&HS volumes.
- T&HS delivered its 10th consecutive quarter of net sales volume growth, with clean label growth globally, but operating income fell to $95 million on tapioca and manufacturing costs.
- F&II–U.S./CAN operating income $52 million, down $29 million, on high manufacturing expenses at Argo; F&II–LATAM $109 million, hit by a stronger Mexican peso and the August earthquake in Colombia.
- Full-year 2026 guidance cut: reported diluted EPS $8.04-8.49, adjusted $9.25-9.70; net sales flat; adjusted operating income down mid-teens; F&II–U.S./CAN operating income down 35-40%; cash from operations $650-750 million; capex $450-490 million.
- Dividend raised to $0.83 per quarter (12th consecutive year of increases); $85 million of buybacks so far toward a $100 million target.
- CEO Jim Zallie: "the recovery is taking longer than we expected"; integration planning for the pending Tate & Lyle acquisition is progressing.

### [Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle (press release, Exhibit 99.1)](https://www.sec.gov/Archives/edgar/data/1046257/000162828026041921/exhibit99-1xingredionann.htm)

Report · 2026-06-08

- On June 8, 2026 Ingredion announced a recommended all-cash offer for Tate & Lyle PLC, implying a total enterprise value of approximately £3.7B ($5.0B).
- Tate & Lyle shareholders to receive 595 pence per share, an approximate 59% premium to the May 13, 2026 close, plus capped final and interim dividends.
- Rationale: broaden Ingredion's specialty platform across texturants, sugar reduction and fortification, add multi-ingredient systems and recipe development, and combine supply networks across the Americas, EMEA and Asia Pacific.
- Run-rate net cost synergies of approximately $130 million fully realised by the end of 2030, with one-time costs of approximately $175 million; adjusted EPS accretive in the first year after completion.
- Financing from cash, new debt and if needed a committed bridge; pro forma net leverage about 3.0x at completion, reduced to about 2.5x within about 18 months; strong investment-grade profile kept.
- Huber Equity Corporation gave an irrevocable undertaking for about 16.8% of Tate & Lyle shares; completion expected in the second half of 2027 via a UK scheme of arrangement.
- Tate & Lyle: approximately 5,000 employees in 37 countries, revenue from continuing operations of £2.0 billion for the year ended 31 March 2026.

### [Ingredion Q3 2026 earnings call transcript](https://www.tradingkey.com/news/transcripts/262284977-)

Executive talk · Jim Zallie, Chairman, President and CEO · 2026-11-05

- Zallie: Q3 "fell short of our expectations"; profitability hit by higher manufacturing costs at Argo, higher input costs and a stronger Mexican peso, while volumes grew in T&HS and F&II LatAm. Full-year adjusted EPS cut to $9.25-9.70.
- Argo: production stable for two quarters but "production recovery and financial recovery are at different stages"; about two-thirds of the profit shortfall came from input and operational costs (below-par corn yields, maintenance spend), the rest from softer volumes.
- Demand: since August, softer U.S./Canada food and beverage volumes as consumers buy fewer units or trade down; Zallie also cited SNAP benefit cuts. Europe, Asia Pacific and LatAm held up; LatAm volumes grew 4%.
- Tapioca: Thai root shortage pushed tapioca starch prices up roughly 45% since January and Ingredion's tapioca costs up about 65% year on year, recovered with about a one-quarter lag; no material substitution by customers.
- T&HS: 10th straight quarter of volume growth; Clean Label Solutions sales up 8% year-to-date, Asia Pacific more than 30%; pipeline above one-third of last year's clean label sales.
- Tate & Lyle: shareholders approved in July; regulatory and antitrust reviews ongoing; close still targeted for the second half of 2027; integration planning underway. Further plant consolidations are on hold until the combined network is understood.
- New CFO Diego Reynoso (joined October 1, ex-Boston Beer, Tyson Foods, Constellation Brands) is focused on Argo costs; FY2026 cash from operations now $650-750 million, capex $450-490 million.

### [Ingredion Q2 2026 earnings call transcript](https://allmind.ai/earnings/event/2942383)

Executive talk · Jim Zallie, Chairman, President and CEO · 2026-08-04

- Q2 2026 in line with expectations: net sales up 1% to $1.85 billion, adjusted operating income down 5% to $258 million; T&HS posted its second highest quarterly operating income ever and its ninth consecutive quarter of volume growth (up 7%).
- Argo: after an April 10 thermal event took down the germ processing unit (back in early June), the plant exited June at normal production rates; extra capital is going into redundancy such as saccharification tanks.
- Tate & Lyle: shareholders approved the deal; regulatory approval needed in 11 jurisdictions including the US and EU. The deal adds $2.7 billion of revenue, $130 million of run-rate synergies by 2030, and more than 15% adjusted EPS accretion in the first full calendar year, with net leverage below 2.5x within 18 months.
- After the combination, more than half of revenue will come from T&HS, which will "accelerate our shift toward higher value and higher margin solutions".
- Growth initiatives: Sanstar partnership in India (pharma excipients), Ask Ingredion AI formulation platform, Benicaros immune-health prebiotic acquisition, plant-based PFAS-free packaging barriers and bio-based corrugating adhesives.
- Portfolio: Pakistan majority stake sold, Cabo (Brazil) plant closed; FY2026 adjusted EPS guidance $10.30-10.90 reaffirmed after amending for Pakistan; capex $450-490 million.
- Tapioca root prices up more than 40% since the start of the year; Zallie sees the impact as temporary, not structural.

## Questions about Ingredion Incorporated

### What does Ingredion do?

Ingredion transforms corn, tapioca, potato and other plant materials into starches, sweeteners, texturizers and other ingredients for food, beverage, brewing, animal nutrition and industrial customers.

### What was Ingredion's revenue in 2025?

Net sales were $7,219 million in 2025, down 3 percent from $7,430 million, with net income attributable to Ingredion of $729 million.

### How many employees does Ingredion have?

Approximately 11,200 employees at end-2025, about 3,200 of them in the U.S. and Canada.

### Is Ingredion buying Tate & Lyle?

Yes. Ingredion agreed on June 8, 2026 an all-cash recommended offer for Tate & Lyle, with completion expected in the second half of 2027.

### Who leads Ingredion?

Jim Zallie is Chairman, President and CEO; Diego Reynoso became EVP and CFO on October 1, 2026.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
